BTCY (Biotricity) חוב כולל להון

Biotricity, Inc. (BTCY) has created an environment for remote cardiac monitoring where cardiologists utilize Bioflux sensors with full patient loyalty and FDA support. The business relies on integrating wearable ECG devices with cloud-based analytics for the early detection of diseases. The company's price chart shows that the separate_debt_total_eq metric is 0.00, while quotes are rising driven by SaaS subscriptions and AI-powered arrhythmia diagnostics.

Consistent confidence among cardiologists in the accuracy of Biotricity, Inc. (BTCY) heart monitoring systems creates a foundation for sustainable business growth in telemedicine. The debt-to-equity ratio determines the company's level of dependence on borrowed funds, where an increasing coefficient signals a rising debt load, as clearly reflected in the company's financial leverage history.